Mimedx MDXG
NASDAQ MDXG
$4.66 -0.01 (-0.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Mimedx (MDXG) Restructuring Costs (2023)

Updated

Mimedx (MDXG) reported Restructuring Costs of $208,000 for Q3 2023, down 93.6% from the prior quarter.

Analysis

Mimedx (MDXG) Restructuring Costs (2023) Analysis & Trends

Over the twelve months ended Sep 30, 2023, Mimedx's Restructuring Costs came in at $3.46 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Mimedx 680.53 Mn 76.72 Mn 44.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 208,000.00
Jun 30, 2023 3.26 Mn
API Access

Mimedx Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=MDXG&period=max&api_key=YOUR_API_KEY